There are at least three hypotheses until now: (i) mCRPC develops independently of androgen, (ii) PCa cells acquire alterations in AR making it more sensitive to low androgen levels, or (iii) there is intratumoral androgen production. The gene discussed is AR; the disease is posterior cortical atrophy.